Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform
Abstract Background The NOTI chelating scaffold can readily be derivatized for bioconjugation without impacting its metal complexation/radiolabeling properties making it an attractive building block for the development of multimeric/-valent radiopharmaceuticals. The objective of the study was to fur...
        Saved in:
      
    
          | Main Authors: | Sebastian Martin, Moritz-Valentin Schreck, Tobias Stemler, Stephan Maus, Florian Rosar, Caroline Burgard, Andrea Schaefer-Schuler, Samer Ezziddin, Mark D. Bartholomä | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | SpringerOpen
    
        2024-12-01 | 
| Series: | EJNMMI Radiopharmacy and Chemistry | 
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41181-024-00314-7 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials        
                          
 by: Alexander Konopnicki, et al.
 Published: (2024-12-01)
- 
                
                    Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System        
                          
 by: Zsófia Sára Mikó, et al.
 Published: (2024-10-01)
- 
                
                    Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study        
                          
 by: Sofía González-Rueda, et al.
 Published: (2024-10-01)
- 
                
                    Selective light olefin synthesis with high ethylene abundance via CO2 hydrogenation over (Ga-In)2O3/SSZ-13 catalysts        
                          
 by: Yasemen Kuddusi, et al.
 Published: (2025-01-01)
- 
                
                    Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry        
                          
 by: Pete Tually, et al.
 Published: (2024-12-01)
 
       